Table 2.
Outcome variables in 2 groups and predict of variables by logistic regression
| Variables | INH (n=86) | Misoprostol (n=90) | P-value | OR (95% CI) (misoprostol/INH) |
|---|---|---|---|---|
| Primary outcomes | ||||
| Hysteroscopy entrance | ||||
| Yes | 67 (77.9) | 45 (50.0) | 1.000 | 1.00 |
| No | 19 (22.1) | 45 (50.0) | 0.0001 | 0.57 (0.43–0.75) |
| Secondary outcomes | ||||
| Non responses | ||||
| Yes | 19 (22.1) | 45 (50.0) | 1.000 | 1.00 |
| No | 67 (77.9) | 45 (50.0) | 0.0001 | 1.75 (1.32–2.30) |
| Intra uterine pathology | ||||
| Normal | 19 (22.1) | 12 (13.3) | - | 1.00 |
| Polyp | 31 (36.0) | 42 (46.7) | 0.090 | 0.71 (0.26–1.95) |
| Myoma | 17 (19.8) | 15 (16.7) | 0.513 | 0.75 (0.56–0.99) |
| Asherman’s syndrome | 0 (0) | 4 (4.4) | 0.035 | 0.94 (0.22–0.99) |
| Septum | 6 (7.0) | 4 (4.4) | 0.612 | 0.63 (0.07–5.10) |
| Atrophy | 2 (2.0) | 2 (2.2) | 0.530 | 0.90 (0.27–3.01) |
| Focal hyperplasia | 10 (11.6) | 7 (7.8) | 0.554 | 1.05 (0.95–1.16) |
| Product of conception | 1 (1.2) | 4 (4.4) | 0.035 | 0.75 (0.56–0.99) |
| Max Hegar size in nonresponses | 3.73±1.28 | 3.84±1.04 | 0.726 | - |
Values are presented as number (%) or mean±standard deviation.
CI, confidence interval; OR, odds ratio; INH, isonicotinic acid hydrazide.